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ABSTRACT
ST Monitoring on the Programmer for Implantable Cardioverter Devices
Sarina Satya
Cardiovascular disease is one of the most prevalent causes of death. However, if
cardiovascular disease is identified early and treated appropriately, the mortality in
patients with cardiovascular disease can be hugely reduced. For several decades, 12-Lead
ECG has been the standard technique used to identify ischemia, and recent studies have
shown that intracardiac electrogram has many benefits over external monitoring such as
holter. ST Monitoring feature has been added to St. Jude Medical intracardiac
cardioverter defibrillators (ICD) to leverage the ECG technology for identifying
cardiovascular disease. This algorithm monitors the intracardiac electrogram to detect
and report patterns which could be related to ischemic events. This feature is expected to
enhance the process of identifying ischemia and infarction, and provides long-term
management of the disease.
In order to support the new implantable devices with ST Monitoring capability,
the programmer software was updated to support this new feature in the device. This
thesis discusses the work on the programmer. Chapter 1 begins with a background of how
monitoring technology in an implantable device can benefit the patients facing high risk
of myocardial infarction. Chapter 2 states the objective for the work on the programmer.
Chapter 3 describes the implementation and the application of this feature. Conclusion
and future development are discussed in Chapter 5.
Keywords: Merlin.net, St. Jude Medical, Cardiac Device, ST Monitoring

iv

TABLE OF CONTENTS
Page
LIST OF FIGURES ........................................................................................................... vi
I.

INTRODUCTION ...................................................................................................... 1
Physiology of the heart ................................................................................................... 3
Action potential in the cardiac muscle............................................................................ 5
Electrocardiogram and the cardiac cycle ........................................................................ 9
Electrocardiogram and cardiac diseases ....................................................................... 10
ST-segment monitoring and Ischemia Detection.......................................................... 13

II.

OBJECTIVE ............................................................................................................. 17
Requirements for the Programmer Application............................................................ 17
ST Monitoring Use Case on the programmer ............................................................... 18
Programmer Application............................................................................................... 21

III.

IMPLEMENTATION AND RESULTS............................................................... 27

ST Monitoring parameters setup on the programmer................................................... 28
Setup ST Monitoring Heart Rate Zones ....................................................................... 30
Setup ST Monitoring representative beat ..................................................................... 31
Positive Threshold and Negative threshold .................................................................. 32
Suggested Thresholds ................................................................................................... 33
ST Monitoring diagnostics............................................................................................ 34
V.

CONCLUSION......................................................................................................... 37

REFERENCES ................................................................................................................. 39

v

LIST OF FIGURES
Figure

Page

Figure 1 Heart Disease and Stroke Statistics [3] ............................................................... 1
Figure 2 The Heart [25] ..................................................................................................... 4
Figure 3 Cardiac muscle characteristics [25].................................................................... 5
Figure 4 Cardiac Action Potential Phases [18] ................................................................. 7
Figure 5 Cardiac Cycle [19] .............................................................................................. 8
Figure 6 Normal Electrogram .......................................................................................... 10
Figure 7 Current of injury in electrocardiogram [19] ..................................................... 12
Figure 8 Extracellular K+ activity [6] ............................................................................. 13
Figure 9 Possible STEMI electrocardiogram [14]........................................................... 14
Figure 10 ST Monitoring Workspace ............................................................................... 28
Figure 11 Threshold Setup................................................................................................ 29
Figure 12 Parameter Setup............................................................................................... 30
Figure 13 Heart Rate Zone Setup ..................................................................................... 31
Figure 14 Baseline Selection ............................................................................................ 32
Figure 15 Program Suggested Thresholds ....................................................................... 34
Figure 16 ST Trend panel ................................................................................................. 34
Figure 17 Histogram Overlay Window............................................................................. 35
Figure 18 ST Episode Log ................................................................................................ 35
Figure 19 ST Episode Waveforms..................................................................................... 36

vi

I.

INTRODUCTION
Cardiovascular disease is the number one cause of death globally. According to

the World Health Organization, this disease claims more than 17 million lives a year,
representing 30% of all global deaths [1]. In the United States, there are 1.26 million
cases of recurrent coronary attack each year, out of which 37% of the people die within a
year [2].

Figure 1 Heart Disease and Stroke Statistics [3]

Although cardiovascular disease is prevalent and mortality rate is high, many
studies have confirmed that if heart diseases symptoms are identified early, it is possible
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to minimize the development of the disease, reduce the risk of heart attack, and increase
the mortality in patients with heart disease. However, many patients with heart diseases
do not receive timely treatment. During early stage of the disease, many patients do not
feel any symptoms for a long time and no treatment or preventive measure is given until
the problem develops into a life threatening stage [4]. Also, when patients with acute
symptoms are in the hospital, there is still a need to improve the time taken to diagnose
the disease which would hugely impact the morbidity and mortality of the patients [11]
Patients who are dependent on implanted device are facing the highest risk of
such disease, and EGM patterns have been known to be the best tool to identify their
heart anomalies such as ischemia. Therefore, St. Jude Medical collaborated with Angel
Medical Systems to co-develop an algorithm to monitor heart beats from an implanted
device. This algorithm monitors the intracardiac EGM to detect and report patterns found
in the patient that could be indicators of symptoms. These systems indicate severe heart
disease which could lead to fatal ventricular fibrillation or infarction. With an implanted
device, these patterns can be easily detected even in patients that are asymptomatic. This
feature, called ST Monitoring, is expected to be hugely beneficial to these patients,
provided that approximately 70 – 90 % of all ischemia detectable with EGM is silent [4].
This chapter will provide a background of the heart and the foundation of using
the intracardiac EGM for diagnosing heart diseases. Following that discussion there will
be an overview of the benefits of an implantable device that provides chronic monitoring
of the ST-Segment.
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Physiology of the heart
The human heart is a powerful muscular pump. It contracts seventy times per
minute on average and pumps about five liters of blood each minute to all organs and
tissues. The body needs the oxygen in the blood to carry out normal functions. The
circulation of blood also removes waste from those organs and tissues, and delivers
deoxygenated blood to the lungs. This is also crucial for the body to carry out normal
functions.
The heart has four chambers, two on the left side and two on the right side. The
two top chambers are known as the right and left atrium, and the two bottom chambers
are the right and left ventricles. The right and the left chambers are separated by a wall
called the septum.
The heart is connected to a few large blood vessels which serve as the routes for
blood to flow in and out of the heart. There are two major types of blood vessels: arteries
and veins. The arteries carry blood from the heart to the body, and the veins carry blood
from the rest of the body back to the heart. For example, the aorta artery carries nutrient
rich blood away from the heart while the superior vena cava and the inferior vena cava
take the blood from the rest of the body into the right atrium. The pulmonary artery
carries oxygen depleted blood from the heart to the lung, and the pulmonary veins take
blood from the lungs to the left atrium.
In addition, the heart comes with valves that prevent blood from flowing in the
wrong direction. These valves are fibrous tissues found between the atria and the
ventricles, as well as between the great arteries and at the top of the ventricles. The mitral
valve connects the left atrium with the left ventricle, and the tricuspid valve connects the
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right atrium with the right ventricle. The aortic valve and the pulmonary valve are found
at the base of the corresponding arteries.

Figure 2 The Heart [25]

On the outside, the heart is wrapped around by the pericardium and on the inside
it is covered by a smooth lining called the endocardium. The middle layer, which is the
thickest layer of the heart, is made up of a special type of muscle called cardiac muscle or
myocardium.
As shown in Figure 3 below, the cardiac muscle cells are striated, with muscle
fibers parallel to each other branched and joined at various locations resulting in
intercalated disks that form a functional network. The pumping action of the heart is the
result of coordinated contraction of these cardiac muscles in the heart.
Unlike the skeletal muscles, which contract in response to the stimulus from the
nerve terminals attached to them, the cells in the cardiac muscles pass electrical impulses
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to their neighbors through special channels called gap-junctions. The heart only needs to
be stimulated at one location and the electrical impulses get passed on to the rest of the
heart muscle, causing it to contract.

Figure 3 Cardiac muscle characteristics [25]
Action potential in the cardiac muscleF
Electrical impulses in the heart cause action potential, which is “the change in
membrane potential occurring in nerve, muscle, or other excitable tissue when excitation
occurs” [17]. Action potential results in the contraction of the cardiac muscle and initiates
the pumping action of the heart, and the electrical mechanism associated with action
potential provides a way to identify abnormal heart function.
The cell membrane of cardiac muscle is permeable to the ions of elements that are
important to the functioning of the heart. The three main elements are potassium,
calcium, and sodium. There are “gates”, or ion channels, on the cell membrane that
control the movement of these charged elements in and out of the cell. As a result of the
movement of these ions across the cell membrane, there is a difference in electrical
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potential between the inside and outside of a cell, and that is called the membrane
potential.
The cells in the cardiac muscle can either be resting or electrically stimulated. A
cardiac cell that is not stimulated by an electrical impulse is called a resting cardiac cell.
It has less positive charges inside than outside, so the net electrical potential across the
cell membrane is negative. When a cardiac cell receives an electrical stimulus from an
adjacent cell, it is electrically stimulated. The ion channels open and rapid influx of the
sodium ions results in depolarization of the cell and causes the cell to contract.
After depolarization and contraction, the cardiac cells repolarize as positive
potassium ions (K+) are pumped out of the cells. The cells return to negative potential.
When the cardiac cells are repolarizing, the cells are in refractory and cannot depolarize.
The movement of charged ions causes an electrical current which gets transmitted to the
adjoining cell and causes it to contract. This depolarization and repolarization continues
across a large scale of cardiac muscle contraction leading to the pumping action of the
heart’s chamber.
The diagram below shows the different phases of action potential that correspond
to the voltage changes that are present.
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Figure 4 Cardiac Action Potential Phases [18]

The cardiac action potential lasts over 300 msec, which is about fifteen times
longer than the skeletal muscle action potential, and it consists of five phases. As
described above, the phases of the action potential are associated with the movement of
the charged ions across the cell membrane. The upstroke in Phase 0 corresponds to rapid
depolarization due to a rapid influx of Na+ ions through the fast sodium channels. These
channels close abruptly after only a small fraction of a second, and abruptly decrease the
permeability of sodium across the cell membrane, and the net outward movement of the
potassium ions causes the cross membrane voltage to decline in Phase 1. In Phase 2, the
plateau in voltage changes is due to a balance between inward flow of calcium ions and
outward flow of potassium ions. The calcium channels close at the end of the plateau,
while the potassium channels remain open. The net outward flow of potassium ions

7

causes a fall in the membrane potential which characterizes the depolarization in Phase 3.
The voltage continues to decrease until it reaches the resting membrane potential
represented by Phase 4. The cycle repeats when the next electrical stimulus occurs.

The Cardiac Cycle
The electrical impulses that are transmitted through the atrium and ventricles
cause coordinated contraction of the cardiac muscles and the pumping action of the heart,
which is known as the heartbeat. The sequence of events that occurs through the heart
from the beginning of one heartbeat to the beginning of the next is known as the cardiac
cycle.

Figure 5 Cardiac Cycle [19]
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As shown in the diagram above, the cardiac cycle consists of two different stages.
During the diastole stage the atria or ventricle relax and fill with blood, while during the
systole stage, the muscles of the atria or ventricle contract and pump blood out.
The heart contains pacemaker cells, such as the collection of cells at the sinoatrial
node, which can initiate electrical impulses rhythmically. In the beginning of the cycle,
the sinoatrial node depolarizes and initiates an action potential and the atria contracts.
The action potential travels through the A-V bundle and is delayed for about a small
fraction of a second before entering into the ventricles causing the ventricles to contract.
As a result, the atria contract ahead of the ventricle and fill the ventricles with blood
before ventricular contraction begins.
Electrocardiogram and the cardiac cycle
The electrical activity throughout the cardiac cycle can be measured by electrodes
placed on the surface of the skin, or by more invasive method such as catheter or
implantable pacemaker or an implantable cardioverter defibrillator (ICD). The voltage
between pairs of these electrodes, from different directions, is often referred to as the
vectors. They are also referred to as leads. Electrocardiogram is the recording and
graphical presentation of such electrical activity over time.
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Figure 6 Normal Electrogram
The electrogram in the above figure shows the electrical activity of a normal
ventricular muscle fiber during normal function. The P, QRS, and T waves correspond to
different stages of the cardiac cycle. The P wave represents depolarization of the atria,
and the QRS waves represent the depolarization of the ventricles, which is slightly before
the onset of ventricular systole. The T wave represents the stage of repolarization of the
ventricles, when the ventricles begin to relax.
Electrocardiogram and cardiac diseases
Abnormalities or disease of the heart can change the electrical signal conduction
pattern and cause abnormal electrical potentials around the heart. In a study done by
Kleber and his co-workers [6], transmembrane potentials from pig ventricular cells were
recorded before and after occlusion of the left anterior descending artery. This study
reported the observation of extracellular potassium activity increased from 4 mM to
around 14.7 mM during 15 minutes of ischemia. A few years later, another study also
provided similar observation [10]. This study was done on 11 open chest dogs during a
30 min ligation of the left anterior descending coronary artery, and extracellular K+
changes during acute myocardial in the ischemic zone and normal myocardium were
10

measured. Before coronary ligation, extracellular K+ ranged from 4.0 +/- 0.3 to 4.3 +/0.3 mM in the extracellular zone. After ligation, extracellular K+ accumulated in the
ischemic reached 9.8 +/- 2.0mM, while the central ischemic zone reached a much higher
level (14.4 +/1 4mM). In contrast, no significant changes in K+ occurred in the normal
zone throughout the ischemic period. These studies suggested that relative potassium
permeability predominates during ischemia, which leads to an increase in extracellular
K+, resulting in abnormal membrane potential in the ischemic tissue and membrane
depolarization. In addition, it has also been found that an extracellular current, known as
current of injury, was found flowing from the injured epicardial border zone towards
normal myocardium[22].
The current of injury is the result of the damaged heart tissues being partially or
totally depolarized all the time. Excessive extracellular K+ in the injured tissue causes an
abnormal potential gradient at the extracellular area between the injured zone and the
normal zone. This potential gradient causes a current to flow from the injured areas
towards the normally polarized areas. When this current of injury is detected by the
electrocardiogram, the ST-segment and the TQ segment on the electrocardiogram will
appear to be shifted.
Ischemia is a common cause of current of injury. During ischemia, normal
membrane polarization cannot be maintained due to lack of blood supply and other
nutrients. As a result of this current of injury, ST-segment elevation is commonly
observed on the EGM collected from patients with ischemia.
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Figure 7 Current of injury in electrocardiogram [19]

In addition, Kebler’s study also found that there was an increase in extracellular
potassium accumulation occurred when heart rate was increased abruptly from 60 to 170
beats/min [6]. The effect of an abrupt change in heart rate was observed during three
different time intervals: prior to occlusion, during occlusion, and during reperfusion. In
the diagram below, the heart rate was increased abruptly from 60 beats per minute to 170
beats per minute for the times indicated by the bars.
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Figure 8 Extracellular K+ activity [6]

As shown in the diagram, when the heart rate was increased abruptly from 60 to
170 beats per minute, there was a more pronounced increase in K+ accumulation.
Many studies have been conducted to gain deeper understanding of the
mechanisms of the potential difference in cardiac tissues during ischemia. It has been
suggested that the cellular loss of potassium is largely due to the opening of ATPsensitive K+ channels. Blockers for the Katp channels were found to partially prevent
action potential shortening and extracellular K+ accumulation. [5, 7, 8, 9]
ST-segment monitoring and Ischemia Detection
Ischemia can be symptomatic, asymptomatic, consistent, or unstable. All types of
ischemia can be related to the interruption of action potential and delayed or obstructed
conduction through the cardiac muscle. Because interruption of the electrical conduction
in the cardiac muscle can result in the alteration of ST-segment on the ECG waveform,
objective evidences of myocardial ischemia may be obtained from monitoring the ST
segment changes
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ST-segment elevated ischemia is a common cause of myocardial infarction.
Myocardial infarction is commonly classified as STEMI, which is marked by an
elevation of the ST segment, or NSTEMI, which is not. A recent report from the National
Center for Health Statistics showed that 500,000 out of 896,000 of hospitalizations due to
MI are related to a shift in ST-segment [13].

Figure 9 Possible STEMI electrocardiogram [14]

12-Lead electrocardiography, vectocardiography, and ambulatory
electrocardiogram are common and effective methods for identifying ST-segment
elevation. These methods provide important information to guide management and
determine prognosis, which are critical in reducing the time to treatment for the patients.
[12].
Recent publications have also confirmed the feasibility of using subcutaneous
electrodes on implanted devices. Such devices are already being used for detecting other
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cardiac events, such as ventricular fibrillation [20]. These studies have also shown that in
many ways, implanted devices can be used for the detection of ischemia and provide
superior ST-segment monitoring result. Some obvious benefits of using implanted device
for ST-segment monitoring are as follows:
(1) For patients who have previous infarction and are at higher risk of recurrent
infarction, ST monitoring feature in an implanted device could provide early detection of
a serious myocardial infarction and timely notification. The OPTIMAAL trial showed
that the majority of sudden deaths (57%) were due to recurrent infarction[21]. The
MADIT II study has also shown that implanted defibrillator improves survival for
patients with prior myocardial infarction.
(2) Many ICD patients also suffer advance state of cardiac diseases such as
coronary artery disease and left bundle-branch block. For these patients, this feature will
provide important diagnostic information including chronic intracardiac EGM and events
summary information immediately. This information can be used to differentiate STsegment deviation that results from conditions other than myocardial infarction and avoid
unwarranted thrombolytic therapy or emergency angiograph. In the case of acute
myocardial infarmtion, such information can shorten time to treatment in case of critical
events such as ventricular fibrillation or identify other complicaqtion such as ventricular
aneurism. Since the majority of deaths from myocardial infarction occur within the first
one to two hours after symptom onset, ACC/AHA 2004 Guidelines for the Management
of Patients with ST-elevation Myocardial Infarction recommends to keep ischemic time
to within 120 minutes and medical contact to balloon (i.e. treatment with percutaneous
coronary intervention) time within 90 minutes.
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(3) Patients with coronary artery disease often develop changes over the course
of the disease. With implanted device that monitors the ST-segment, changes can be
tracked in the ischemic profile of these patients to enable early treatment and reduce
future cardiac events.
(4) Monitoring ST-segment changes using holter monitoring is cumbersome.
Multiple electrodes and their associated wires need to be managed, and may affect the
quality of life for the patients. An implanted device does not require skin electrodes, and
external wires. In addition, noise and baseline can be controlled more effectively in an
implanted device than holter monitor.
(5) ST-segment monitoring feature in an implanted device may be connected to
remote monitoring system. With current state-of-the-art wireless technology, diagnostic
data, including related EGM, can be extracted from the implanted device remotely and
sent to a remote patient database for storage. The data can be made available to the
physician in a timely manner as well as for future reference.
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II.

OBJECTIVE
The objective of this project is to update the existing programmer software to

extract and interpret the ST Monitoring data from the implanted device, as well as
provide an interface for adjusting the feature in the device. The development of the ICD
ST Monitoring firmware started in 2007, and the programmer software had to be updated
to make the ST Monitoring diagnostics data available to physician.
To accomplish this objective, understanding the requirement and the programmer
software thoroughly is critical, because the programmer software was updated according
to the requirement. In addition, it is also important to understand the programmer
software structure and the techniques used to develop the programmer software. This
chapter will first provide a high level discussion of the requirement for the programmer
ST monitoring feature, following that this chapter will provide an overview of the
existing programmer application software.
Requirements for the Programmer Application
 External Instruments Interface Specification (EIIS):
The interface between the programmer and the implantable device is defined in a
set of requirement documents called the External Instruments Interface
Specification (EIIS). This document provides information including the
following:
•

physical layout of the data in the device

•

mechanism to retrieve the data

•

formulae to interpret the data, and
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•

Procedures to get the device to perform required functionality.

 Programming Logic Requirements Specification (PLRS)
Parameters provide meaningful information representing the current state of the
device. Most of these parameters also correspond to the information presented on
the programmer screen and some of these parameters can be programmed from
the programmer screen. The full list of these parameters, and the related display
and logical usage of these parameters are found in the requirement called the
Programming Logic Requirement Specification (PLRS). This requirement also
provides the formulae for correlating these parameters with the information
retrieved from the device.
 Use Case: Feature requirement
The behavior of features supported by the programmer is defined in various Use
Case Requirements. There is one corresponding Use Case Requirement for each
feature. For example, there is one use case for implanted device connection, a
separate use case for managing the programmable parameters, and a separate use
case for ST Monitoring, and so forth.
ST Monitoring Use Case on the programmer
The programmer is responsible for extracting the ST Monitoring data from the
implanted device. This is done during initial interrogation during a patient follow-up
session. The data read is interpreted and displayed on the ST Monitoring Workspace of
the programer. This workspace also provides the ST Monitoring Setup window which
can be used to program the parameters related to this feature. The ST Monitoring
workspace provides graphical display of the diagnostics in three different groups: ST
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Deviation Trend; ST Episode Log, and ST Histogram Data, and each of these groups
present information pertaining to four different heart rate zones.
 ST Monitoring Heart Rate Zones
ST Monitoring diagnostics data are collected from four different heart rate
zones: Resting Heart Rate Zone, Elevated 1 Heart Rate Zone, Elevated 2 Heart
Rate Zone, and Elevated 3 Heart Rate Zone. Each zone is defined by a set of
maximum and minimum beat-per-minute. The resting zone can be programmed to
different values by the user via the programmer while the boundaries for the other
heart rate zones are adjusted automatically by the programmer.
 ST Monitoring Deviation Trend
This information consists of the deviation of the ST segment compared to
the isoelectric segment over a period of time. These deviations can be displayed
graphically on the programmer as a trend. The deviation trend for all four
different heart rate zones are all retrieved from the device. The programmer
application converts the raw value to displayable value in “mV” unit. The
maximum ST Deviation during the sampling period is also calculated by the
programmer.
 ST Monitoring Episode Log
When an elevation or depression of the ST-segment is detected and the
shift exceeds the programmed thresholds, the device will store summary
information related to each of the incidences. This information is grouped
together and summarized in an ST episode. The information captured includes the
following:
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•

ST Episode Heart Rate at onset (bpm)

•

Max ST Shift (%)

•

ST Episode Duration (D:H:M:S)

•

Stored EGM

The device stores up to 90 ST episodes. However, only the oldest and the
most recent 29 episodes are displayed on the programmer screen. In addition,
only the oldest and four of the most recent ST episodes will be provided with
associated stored EGM. The stored EGMs are collected from a wideband channel
with RVtip to Can configuration. Additional processing by the programmer
application is required before they are displayed. New VT/VF Episodes within 15
Minutes of any ST Episode are also collected and displayed on the same
workspace.
 ST Monitoring Histogram
The ST Histogram contains the total number of beats for each previously
defined ST deviation range in each of the four heart rate zones. The histogram
data are collected over time, and displayed graphically on the programmer screen
during a patient follow-up session.
 ST Monitoring Setup Parameters
ST Monitoring Setup Parameters hold the values used by the device for
the detection of ST deviation and ST Episode. These parameters can be
programmed by the user to different values from the ST Monitoring workspace.
These parameters include the following:
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•

Isoelectric Start: This parameter determines the starting point for the
isoelectric interval for each heart rate zone.

•

Isoelectric duration: This parameter determines the time period of the
isoelectric interval for each heart rate zone.

•

ST Start: This parameter determines the starting point for the ST
interval for each heart rate zone.

•

ST Duration: This parameter determines the time period of the ST
interval for each heart rate zone.

•

Positive Threshold: This parameter sets the positive threshold for each
heart rate zone.

•

Negative Threshold: This parameter sets the negative threshold for
each heart rate zone.

 ST Monitoring Suggested Thresholds
For the positive and negative threshold values, the ST Monitoring feature
provides suggested values for each heart rate zone. The programmer application
calculates the values based on the ST Histogram data using an algorithm
developed from past clinical studies.

Programmer Application
St. Jude Medical Programmer is a computer application that provides clinicians the
option to interact with the implantable pulse generators and defibrillator products. The
programmer application is responsible for communicating with the devices via a
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telemetry wand or other communication technology. User interface with the Programmer
includes touch screen, external keyboard, and the console buttons on the programmer.
On the programmer screen, users can view all the data retrieved from the device,
including the current settings for all the features, diagnostics data collected over time, and
current device status such as the battery longevity. Other actions that can be performed
by the user include performing clinical tests on the device and viewing the results,
programming parameters to different values, viewing the stored EGMs, and printing
reports.
The following section provides an overview of the programmer application structure
and various software development techniques used in building this application. The
implementation of the ST Monitoring feature is based on the existing architecture of the
programmer and similar development techniques.
The programmer application is organized in three layers: User Interface layer,
Business Logic layer, and Device Data Layer. Each of these layers consists of one or
more sub-systems. For example, the data layer consists of the Device Sub-System, the
Communication Sub-System, and the Streaming Data Sub-System. Each of these subsystems is composed of smaller components. The release of the programmer application
consists of all three layers packaged together.
The programmer application development can be classified broadly as framework
development and application extension development. The framework consists of java
classes that support the function of the application extension, while the application
extension consists of java classes which support the use cases. Both framework and
application extension are partitioned into the same components and same subsystems as
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described above. The sub-systems interface with each other by Application
Programmable Interfaces (APIs) or pre-defined events.
At the beginning of each patient follow-up session, each of the sub-systems is
responsible for performing any necessary initialization for that sub-system. Similarly,
when a patient follow-up session ends, each of the sub-system is responsible for
performing any necessary clean-up for that sub system.

 Device Sub System (DSS)
The DSS is responsible for creating the logical representation of a specific device
model and all of its features during a session. It consists of static models that can
be used to create the logical representation of the implanted device when one is
connected to the other. The DSS is also responsible for reading the raw device
data and interpreting the data such that it is meaningful for other sub-systems. In
addition, the DSS provides services that trigger various actions in the implanted
device. These services include program parameters, read or clear diagnostics data,
initiate or terminate clinical tests in the device, and download updated firmware to
the device.

 Communication Sub System (DSS)
The Communication Subsystem (CSS) is a subsystem within the data layer which
provides the capability to establish connections with the implantable device. It
encapsulates the details of a connection, such as the communication protocol,
from other subsystems in the application. CSS creates unique representation of
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each connection, and provides all the services needed to establish and control
each of the connections.

 Streaming Data System (DSS)
The Streaming Data Subsystem (SDSS) is another subsystem within the data layer
which is responsible for managing and controlling data streams such as the
surface EGM, stored EGM, and marker data retrieved from the implanted device.
It also provides services to manipulate the data such as heart rate calculation,
ECG filtering and annotation, marker decoding, and taking freeze capture of the
data stream.

 Graphical User Interface Sub System (GSS)
The GUI subsystem in the GUI layer is responsible for the look and feel of the
programmer screen as well as all the graphical display of the device data. It is also
responsible for providing appropriate actions in respond to user interaction on the
screen.

 Business Process Sub System and Business Rule Sub System (BPSS and BRSS)
The Business Process sub system (BPSS) is responsible for representation of
application logic. All the business processes collaborate with each other and with
the other sub systems. They map the user request from the GUI to appropriate
actions in other sub systems, and trigger a GUI update when those actions are
complete. The Business Rule sub system is responsible for enforcing logical data
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integrity when data is changed. For example, when a user selects a different value
for a particular parameter on the GUI, the Business Rule sub-system will check
for possible conflicts with the programmed value of all other parameters. If a
conflict is found, the GUI sub-system is notified and the conflict will be shown on
the screen to inform the user.

 Software language : Java and OOP
The programmer application is written using the Java programming language and
Object Oriented Programming (OOP) technique. OOP is a software development
technique which is based on the states and activities of real world objects. The
programmer application is built upon the following Java and OOP concepts:
1. Class: In Java language, a class contains the definition of structure,
characteristics, and behavior of a particular thing. It is the blueprint
from which an instance of the thing is created.
2. Instance: An instance is one copy of a class. Different instances of the
same class may have different states at any time when an application is
running.
3. Object: An object is an instance of a class.
4. Thread: A thread is a process, or a single sequential flow of actions
within an application. Java supports running multiple threads at the
same time within the same application process, which makes the
execution of tasks faster and more efficient.

 Software design patterns
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The programmer software applied many software design patterns including the
following:
1. Type-Object pattern: This is used to separate the objects that hold the
information loaded from the pre-defined (or static) model of the
implanted device from the objects that hold and process information
that are only available during the application run time.
2. Finite State Machine (FSM) pattern: This pattern represents the flow
of a process in a finite number of states. Each FSM has a start state and
an end state and can be run as a separate thread. Therefore all the
FSMs can be executed asynchronously. Within an FSM, the transition
from one state to another is triggered by events, and the execution
order of the states is dependent on application runtime conditions.
Most of the device procedure, such as parameter programming and
emergency shock, are implemented using FSM.
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III. IMPLEMENTATION AND RESULTS
In order for the programmer software to support new devices with the ST
Monitoring feature, new parameters and new diagnostic models need to be added to the
programmer software. In addition, new business logic needs to be added to the
programmer software to process the new type of stored EGM related to the ST
Monitoring feature. Implementation of a new algorithm for the calculation of the
recommended ST-Segment thresholds also needs to be added.
The ST Monitoring project on the programmer was completed in July 2008.
The results of this project provided the programmer the capability to turn on this feature
in the implanted device when it is first interrogated and the capability to retrieve all of the
ST Monitoring diagnostic data from the device during subsequent follow-up sessions.
The data retrieved and displayed on the programmer allow the clinician to review the
status of the disease. The data can also be printed to a report in PDF format. User
interface on the programmer also allows the user to program the parameters to adjust the
ST Monitoring algorithm.
As shown in the following screen shot of the programmer, the ST Monitoring
workspace contains the display of the ST Deviation Trend, ST Deviation Histogram, and
the ST Episode Log summary [15]. The “GOTO Setup Button” will bring up additional
windows on which the user can review or program the ST Monitoring parameters.
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Figure 10 ST Monitoring Workspace
ST Monitoring parameters setup on the programmer
The programmer screen for the ST monitoring parameters settings are grouped
under these four tabs: Isoelectric, ST Interval, Positive Threshold, and Negative
Threshold. The user can change these values by touching the parameter panel on the
screen. The diagram below shows the screen shot setting up the negative thresholds.
Other screen shots for these windows can be found in the APPENDIX.
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Figure 11 Threshold Setup
When the user selects the parameter panel under any of the four tabs, a separate
overlay window will be displayed on which the parameter values can be changed directly.
The new values are programmed to the device using the program parameters procedure as
discussed in the previous chapter. As shown in the diagram, there is a different set of
parameters for each of the heart rate zones.
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Figure 12 Parameter Setup
Setup ST Monitoring Heart Rate Zones
From the ST Monitoring Setup window, if the user selects the heart rate zones
panel, the ST Heart Rate Zones overlay window will be displayed. As shown in the
diagram, this window only allows the user to change the minimum and maximum heart
rates for the resting heart rate zone. The minimum and maximum heart rate values for the
other three elevated heart rate zones will be set by the programmer application
automatically based on the selected resting zone values.
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Figure 13 Heart Rate Zone Setup

Setup ST Monitoring representative beat
Besides programming the parameters from the overlay windows, the user can also
set the values for these parameters using the representative beat which is displayed to the
user when the “Select New Beat” button is selected on the ST Monitoring Setup tab.
The representative beat is a reference beat that can be used as the templates for
setting other ST Monitoring parameters. It needs to be selected from a patient’s stored
EGM captured from intrinsic heart beat. If a reference waveform has not been selected,
the user is given the option of selecting a waveform from three different sources of stored
EGM: ST Baseline SEGM, ST Episode SEGM, or a real time captured and frozen EGM.
The figure below shows the window displaying the ST Baseline SEGMs. The user
can select one of the baselines to be the reference waveform from which the
representative beat will be selected. The selected SEGM will be shown in the frozen
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rhythm panel of the overlay window for beat selection. The selected beat will include 200
ms worth of data before the R-peak and 400 ms worth of data following the R peak.

Figure 14 Baseline Selection
Positive Threshold and Negative threshold
The positive and negative thresholds are programmable parameters. These are
reference values used by the ST Monitoring algorithm for the following purposes:
1.

Baseline extraction. During baseline extraction, the ST deviation of the resting
zone heart beats are compared to the thresholds, and the baseline is extracted
only if the ST deviation is less than 50% of the programmed thresholds.

2.

ST-segment analysis. The ST motoring algorithm compare the ST deviation of
a set of beats, and if the deviation is more than the thresholds, the current set is
classified as an ST set. If three consecutive sets are found to be shifted, an ST
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episode is detected. The identified ST episode will be tracked if two
consecutive un-shifted ST sets are detected.

Suggested Thresholds
Threshold values calculated based on the ST diagnostics data collected in the last
seven days are presented to the user along with the programmed values. User can
directly select and program these recommended values to be used as the positive and
negative thresholds.
The suggested thresholds for the resting heart rate zone are displayed on several of
the ST Monitoring setup windows, as shown in the diagram below. User will be
provided a reminder to use the suggested thresholds as the as the programmed thresholds
as shown in the diagram below.

.
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Figure 15 Program Suggested Thresholds
ST Monitoring diagnostics
The ST Monitoring diagnostics data are presented in three panels:

Figure 16 ST Trend panel

The ST Deviation panel shows the deviation trend over a time period of either one
month or six months. The vertical line shows the minimum and maximum ST Deviation
for one day or one week. The small box between the min and max ST Deviation
represents the ST deviation value of the histogram bin containing the largest number of
analyzed beats per day.
The Histogram Data panel shows the ST histogram line graph. The graph is
plotted in “mV” unit on the X-Axis and number of beats in logarithmic scale on the YAxis. The data for each heart rate zone is presented in a different color. If the ST
Histogram Data panel is selected, an overlay window is provided to the user to view the
histogram for any day during the past seven days.
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Figure 17 Histogram Overlay Window

The Episode log panel contains the summary for the ST Episodes. Detail episode
information is shown in a pop up window when the ST Episode Log panel is selected (see

Figure 18 ST Episode Log
By selecting the EGM icon on the table will open the ST Stored EGM Overlay.
As shown in the overlay window, for each ST Episodes there are three associated Stored
EGMs presented along the same time axis: ST Baseline SEGM, Max ST Shift SEGM,
and the ST Episode Detection SEGM.
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Figure 19 ST Episode Waveforms

36

V.

CONCLUSION
The ICD and the programmer software that support the St. Jude Medical’s ST

segment monitoring capability was completed in the fourth quarter of 2008 and has been
well received in the industry. The programmer application has enabled the retrieval of
the ST Monitoring data for the physician and gives physicians more comprehensive ST
segment information over time. This continuous ST-segment information provides early
detection of potential fatal events and helps to capture cardiac episodes that are transient
in nature. As a result, these data can lead to more timely diagnosis and therapy for
patients, and possibly improve patient prognosis
As reported by St. Jude Medical in a press release, "The AnalyST ICD is the only
implantable device that can provide me with ST segment monitoring reports via highquality, intracardiac electrograms, as well as additional ST segment diagnostic reports,"
said Professor Christian Hamm, Ph.D., from the Kerckhoff Klinik who implanted the first
AnalyST ICD in Bad Nauheim, Germany. "This device provides me with new and
valuable information about my patients' ST segments that is otherwise not available and
helps me deliver better and timely care for my patients with arrhythmias and coronary
artery disease."
Currently, physicians are also able to review patients' ST segment changes using
the remote transmissions from the St. Jude Medical Merlin@home transmitter, which is a
wireless remote monitoring system placed in patients' homes. The transmitter sends the
ST diagnostics report to Merlin.net, where the data will be stored in a database for an
extended period of time. Physicians can retrieve and review the data at anytime from any
place where internet service is available. Since the data is stored in a database, physicians
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can review the historic data over a long period of time and compare the trend with the
latest data retrieved. In addition, the Merlin.net system can be configured to provide
notification service to the physician such that whenever critical ST episodes are detected
an alert will be sent to the physician via email or phone call.
Currently the ST Monitoring feature is based on the intrinsic rhythm of the
patient. The baseline stored EGM, ST-Shift measurement, and the threshold calculations
are all based on intrinsic rhythm. To be able to correctly analyze ST-segment shift when
paced heart beats are found in the EGM is a highly anticipated breakthrough.
Understanding of the EGM patterns for ischemic events which involve ventricular pacing
needs to be improved before a reliable algorithm can be made available in an implanted
device. Nevertheless, good progress has been made in this area, and many articles have
been published with suggested criteria for identifying myocardial infarction when
ventricular paced rhythms are part of the waveform.
Better sensing electrodes and lead technology will also be important to the
enhancement of using ST-segment for monitoring of heart disease [16]. Increased
understanding of the patterns of ST-segment shift will make it possible for implanted
devices to provide more information regarding the disease, such as the location of the
occluded vessel or the extent of the infracted cardiac muscle. This type of information
will be extremely helpful for planning and executing the revascularization procedure.
It is important to continuously find ways for advancing the ST Monitoring
algorithm in order to reduce risk wherever possible and contribute to successful outcomes
for every patient.
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